{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:29:42Z","timestamp":1793478582764,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102183"],"award-info":[{"award-number":["82102183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.prp.2026.156689","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:28:43Z","timestamp":1789169323000},"page":"156689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinicopathological characteristics of giant cell tumor of bone and identification of a novel H3F3A p.V36_K37insL mutation"],"prefix":"10.1016","volume":"288","author":[{"given":"Like","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4766-790X","authenticated-orcid":false,"given":"Qiqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156689_bib1","series-title":"Soft Tissue and Bone Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"issue":"3","key":"10.1016\/j.prp.2026.156689_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PAP.0000000000000293","article-title":"The 2020 WHO classification of tumors of bone: an updated review","volume":"28","author":"Choi","year":"2021","journal-title":"Adv. Anat. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1148\/rg.331125089","article-title":"Giant cell tumor of bone: review, mimics, and new developments in treatment","volume":"33","author":"Chakarun","year":"2013","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/j.prp.2026.156689_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156689_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2026.156689_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.22000","article-title":"Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy","volume":"126","author":"Schaefer","year":"2018","journal-title":"Cancer Cytopathol."},{"issue":"6","key":"10.1016\/j.prp.2026.156689_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00428-025-04319-8","article-title":"H3.3G34W immunohistochemistry negative giant cell tumour of bone. Extended analysis of 35 such cases from a single institution in India","volume":"488","author":"Uppin","year":"2026","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.prp.2026.156689_bib8","first-page":"190","article-title":"DNA sequencing of H3F3A mutations in H3.3 immunohistochemistry-negative giant cell tumors of bone","volume":"50","author":"Gong","year":"2021","journal-title":"Zhonghua Bing. Li Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.prp.2026.156689_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032995","article-title":"Giant cell tumor of bone with H3F3B mutation: A case report","volume":"102","author":"Wu","year":"2023","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.prp.2026.156689_bib10","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.21037\/tcr-2024-2564","article-title":"Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases","volume":"14","author":"Du","year":"2025","journal-title":"Transl. Cancer Res."},{"issue":"16","key":"10.1016\/j.prp.2026.156689_bib11","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0000000000000506","article-title":"Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone","volume":"40","author":"Wojcik","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2026.156689_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1746-1596-9-111","article-title":"Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab","volume":"9","author":"Hakozaki","year":"2014","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant","volume":"71","author":"L\u00fcke","year":"2017","journal-title":"Histopathology"},{"issue":"17","key":"10.1016\/j.prp.2026.156689_bib15","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3390\/cancers15174249","article-title":"Histomorphometric Analysis of 38 Giant Cell Tumors of Bone after Recurrence as Compared to Changes Following Denosumab Treatment","volume":"15","author":"Arndt","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.prp.2026.156689_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1634\/theoncologist.2013-0432","article-title":"The clinical approach toward giant cell tumor of bone","volume":"19","author":"van der Heijden","year":"2014","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.prp.2026.156689_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4055\/cios.2012.4.2.107","article-title":"Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor","volume":"4","author":"Kim","year":"2012","journal-title":"Clin. Orthop. Surg."},{"key":"10.1016\/j.prp.2026.156689_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00264-006-0215-7","article-title":"Giant cell tumour of bone: morphological, biological and histogenetical aspects","volume":"30","author":"Werner","year":"2006","journal-title":"Int. Orthop. (SICOT)"},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2012.10.002","article-title":"Giant cell tumor of bone: a basic science perspective","volume":"52","author":"Cowan","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.prp.2026.156689_bib20","doi-asserted-by":"crossref","DOI":"10.2147\/JIR.S557108","article-title":"Kadsua coccinea Extract Alleviates Rheumatoid Arthritis via TNF-\u03b1 Suppression and Gut Microbiota Modulation","volume":"19","author":"Zheng","year":"2026","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.prp.2026.156689_bib21","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1007\/s10787-025-02001-8","article-title":"Targeting the senescence-associated secretory phenotype to modify osteoarthritis in aging","volume":"33","author":"Afzal","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"11","key":"10.1016\/j.prp.2026.156689_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1302\/2046-3758.1411.BJR-2025-0259.R1","article-title":"Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL\/RANK\/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption","volume":"14","author":"Zheng","year":"2025","journal-title":"Bone Jt. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2026.156689_bib24","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1210\/endo.131.5.1425421","article-title":"Evidence for an autocrine\/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone","volume":"131","author":"Ohsaki","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2026.156689_bib25","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9748","article-title":"Giant cell tumor stromal cells: osteoblast lineage-derived cells secrete IL-6 and IL-10 for M2 macrophages polarization","volume":"8","author":"Yang","year":"2020","journal-title":"PeerJ"},{"issue":"8","key":"10.1016\/j.prp.2026.156689_bib26","article-title":"Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective Action","volume":"13","author":"Wang","year":"2026","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41413-026-00511-x","article-title":"Osteoblastic sclerostin loop3-LRP4 interaction required by sclerostin to inhibit bone formation","volume":"14","author":"Wang","year":"2026","journal-title":"Bone Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156689_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jso.26903","article-title":"Sclerostin immunohistochemical staining in surgically treated giant cell tumor of bone","volume":"126","author":"Kelly","year":"2022","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156689_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1369\/00221554231163638","article-title":"Inhibition of RANKL Expression in Osteocyte-like Differentiated Tumor Cells in Giant Cell Tumor of Bone After Denosumab Treatment","volume":"71","author":"Noguchi","year":"2023","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.prp.2026.156689_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","article-title":"Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series","volume":"69","author":"Girolami","year":"2016","journal-title":"J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2026.156689_bib31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/his.13448","article-title":"Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses","volume":"72","author":"Kato","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2026.156689_bib32","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.3390\/cancers13246298","article-title":"State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics","volume":"13","author":"Parmeggiani","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13244-020-00845-y","article-title":"Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities","volume":"11","author":"Alothman","year":"2020","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.prp.2026.156689_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000001388","article-title":"Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology","volume":"44","author":"Treffel","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2026.156689_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4132\/jptm.2016.12.21","article-title":"Denosumab-Treated Giant Cell Tumor of the Bone Mimicking Low-Grade Central Osteosarcoma","volume":"52","author":"Wu","year":"2018","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.prp.2026.156689_bib36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/modpathol.2010.229","article-title":"MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone","volume":"24","author":"Dujardin","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2026.156689_bib37","article-title":"Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156689_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PAS.0000000000002387","article-title":"Malignant Giant Cell Tumor of Bone: A Clinicopathologic Series of 28 Cases Highlighting Genetic Differences Compared With Conventional, Atypical, and Metastasizing Conventional Tumors","volume":"49","author":"Papke","year":"2025","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2026.156689_bib39","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)63432-3","article-title":"USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts","volume":"165","author":"Oliveira","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2026.156689_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.5216","article-title":"Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone","volume":"248","author":"Baumhoer","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2026.156689_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng0314-316","article-title":"Correction: Corrigendum: Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"46","author":"Behjati","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2026.156689_bib42","doi-asserted-by":"crossref","DOI":"10.12890\/2025_005862","article-title":"Check the calcium first in any bone lesion: brown tumour of the talus misinterpreted as giant cell tumour","author":"Eren","year":"2025","journal-title":"EJCRIM [Internet]"},{"key":"10.1016\/j.prp.2026.156689_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1645715","article-title":"Case Report: Management of multiple brown tumors after kidney transplantation","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Endocrinol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:38:00Z","timestamp":1793475480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S0344033826003420"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156689","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological characteristics of giant cell tumor of bone and identification of a novel H3F3A p.V36_K37insL mutation","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156689"}}